New insider activity at CME Group ( (CME) ) has taken place on May 18, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
CME Group’s Chairman and CEO Terrence Duffy has cashed out a notable portion of his holdings, selling 35,000 shares of CME Group stock in a transaction valued at $10,447,865. This sizable sale by the company’s top executive highlights a significant move in insider activity, drawing attention from investors tracking leadership’s confidence and capital allocation decisions.
Recent Updates on CME stock
CME Group’s shares reacted to its Q1 report, where record trading volumes across all six asset classes and strong international growth underscored the company’s role as a key global hedging venue, even though revenue slightly missed consensus. Analysts’ price expectations reflected confidence in CME’s scalable, high-margin model, supported by robust capital returns, expansion of FICC cross-margining, and new product/technology initiatives, while still accounting for headwinds like rate-per-contract compression, rising tech and facilities costs, regulatory uncertainty and signs of softer April activity.
Spark’s Take on CME Stock
According to Spark, TipRanks’ AI Analyst, CME is a Outperform.
CME scores well primarily due to strong financial performance (exceptional margins, strong cash generation, conservative leverage) and a supportive earnings outlook with record operating momentum and a robust product pipeline. The score is held back by weak near-term technicals (below key moving averages and negative MACD), while valuation is acceptable with a solid dividend yield.
To see Spark’s full report on CME stock, click here.
More about CME Group
YTD Price Performance: 12.06%
Average Trading Volume: 2,354,480
Technical Sentiment Signal: Strong Buy
Current Market Cap: $108.3B